CA2235621A1 - Imidazole derivatives and their use as nitrogen monoxide synthase inhibitors - Google Patents
Imidazole derivatives and their use as nitrogen monoxide synthase inhibitors Download PDFInfo
- Publication number
- CA2235621A1 CA2235621A1 CA002235621A CA2235621A CA2235621A1 CA 2235621 A1 CA2235621 A1 CA 2235621A1 CA 002235621 A CA002235621 A CA 002235621A CA 2235621 A CA2235621 A CA 2235621A CA 2235621 A1 CA2235621 A1 CA 2235621A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- phenyl
- imidazolyl
- yield
- mult
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541146A DE19541146A1 (de) | 1995-10-25 | 1995-10-25 | Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren |
DE19541146.3 | 1995-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2235621A1 true CA2235621A1 (en) | 1997-05-01 |
Family
ID=7776625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002235621A Abandoned CA2235621A1 (en) | 1995-10-25 | 1996-10-24 | Imidazole derivatives and their use as nitrogen monoxide synthase inhibitors |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0857171A2 (de) |
JP (1) | JPH11515008A (de) |
AU (1) | AU1300997A (de) |
CA (1) | CA2235621A1 (de) |
DE (1) | DE19541146A1 (de) |
WO (1) | WO1997015555A2 (de) |
ZA (1) | ZA969019B (de) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7166630B2 (en) | 1999-05-25 | 2007-01-23 | Mitsubishi Pharma Corporation | MAG expression promoters |
US8642620B2 (en) | 2005-06-28 | 2014-02-04 | Sanofi | Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
US8889667B2 (en) | 2010-12-29 | 2014-11-18 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US9115086B2 (en) | 2009-06-29 | 2015-08-25 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
US9181231B2 (en) | 2011-05-03 | 2015-11-10 | Agios Pharmaceuticals, Inc | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
US9328077B2 (en) | 2010-12-21 | 2016-05-03 | Agios Pharmaceuticals, Inc | Bicyclic PKM2 activators |
US9365545B2 (en) | 2013-03-15 | 2016-06-14 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US9657004B2 (en) | 2009-04-06 | 2017-05-23 | Agios Pharmaceuticals, Inc | Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use |
US9980961B2 (en) | 2011-05-03 | 2018-05-29 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US10029987B2 (en) | 2009-06-29 | 2018-07-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US11234976B2 (en) | 2015-06-11 | 2022-02-01 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19627310A1 (de) * | 1996-06-27 | 1998-01-02 | Schering Ag | Imidazolderivate als Stickstoffmonoxid-Synthase-Inhibitoren |
ATE224878T1 (de) | 1996-11-04 | 2002-10-15 | Aventis Cropscience Sa | 1-polyarylpyrazole als pestizide |
AUPQ142599A0 (en) * | 1999-07-05 | 1999-07-29 | Fujisawa Pharmaceutical Co., Ltd. | New amide compounds |
US6525051B2 (en) * | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
CN1228338C (zh) * | 2000-06-28 | 2005-11-23 | 久光医药股份有限公司 | 咪唑衍生物或其盐以及含有该衍生物或其盐的药物 |
EP1178038A1 (de) * | 2000-08-04 | 2002-02-06 | Aventis Cropscience S.A. | Fungizide Phenylamidin Derivative |
WO2002092585A1 (en) | 2001-05-11 | 2002-11-21 | Biovitrum Ab | Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
US7718650B2 (en) | 2001-05-11 | 2010-05-18 | Biovitrum Ab | Aryl sulfonamide compounds for treating obesity |
BR0313204A (pt) * | 2002-08-02 | 2005-06-28 | Pharmacia Corp | Métodos para tratamento e prevenção de condições gastrointestinais |
US7449481B2 (en) | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
US20070123572A1 (en) * | 2005-11-28 | 2007-05-31 | Kalypsys, Inc. | Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-amines |
KR20070084574A (ko) * | 2004-12-01 | 2007-08-24 | 칼립시스, 인코포레이티드 | 유도가능 산화질소 신타제 이량체화 억제제 |
WO2007039580A1 (en) * | 2005-10-05 | 2007-04-12 | Nycomed Gmbh | Imidazolyl-substituted benzophenone compounds |
WO2007039578A1 (en) * | 2005-10-05 | 2007-04-12 | Nycomed Gmbh | Imidazolyl-substituted azabenzophenone compounds |
EP2222639A1 (de) | 2007-11-21 | 2010-09-01 | Decode Genetics EHF | Biaryle als pde4-inhibitoren zur behandlung von lungen- und herz-kreislauf-erkrankungen |
WO2014172534A1 (en) * | 2013-04-17 | 2014-10-23 | Massachusetts Institute Of Technology | Metathesis catalysts and methods thereof |
CN105439946B (zh) * | 2014-08-13 | 2018-02-02 | 益方生物科技(上海)有限公司 | 羧酸化合物及其制备方法和用途 |
TWI780281B (zh) * | 2017-12-14 | 2022-10-11 | 丹麥商Nmd藥品公司 | 用於治療神經肌肉病症的化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3541109A (en) * | 1968-06-25 | 1970-11-17 | Du Pont | 1-substituted imidazoles useful in acth reserve assay |
IE40911B1 (en) * | 1974-04-11 | 1979-09-12 | Schering Ag | Imidazole derivatives and process for their manufacture |
FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
FR2643903A1 (fr) * | 1989-03-03 | 1990-09-07 | Union Pharma Scient Appl | Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux |
DE3942475A1 (de) * | 1989-12-22 | 1991-06-27 | Basf Ag | Substituierte salicylsaeurealkylester und verfahren zu ihrer herstellung |
-
1995
- 1995-10-25 DE DE19541146A patent/DE19541146A1/de not_active Withdrawn
-
1996
- 1996-10-24 WO PCT/DE1996/002079 patent/WO1997015555A2/de not_active Application Discontinuation
- 1996-10-24 CA CA002235621A patent/CA2235621A1/en not_active Abandoned
- 1996-10-24 EP EP96944573A patent/EP0857171A2/de not_active Withdrawn
- 1996-10-24 JP JP9516208A patent/JPH11515008A/ja active Pending
- 1996-10-24 AU AU13009/97A patent/AU1300997A/en not_active Abandoned
- 1996-10-25 ZA ZA969019A patent/ZA969019B/xx unknown
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7166630B2 (en) | 1999-05-25 | 2007-01-23 | Mitsubishi Pharma Corporation | MAG expression promoters |
US8642620B2 (en) | 2005-06-28 | 2014-02-04 | Sanofi | Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
US9657004B2 (en) | 2009-04-06 | 2017-05-23 | Agios Pharmaceuticals, Inc | Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use |
US9938259B2 (en) | 2009-04-06 | 2018-04-10 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
US10988448B2 (en) | 2009-06-29 | 2021-04-27 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US11866411B2 (en) | 2009-06-29 | 2024-01-09 | Agios Pharmaceutical, Inc. | Therapeutic compounds and compositions |
USRE49582E1 (en) | 2009-06-29 | 2023-07-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US9115086B2 (en) | 2009-06-29 | 2015-08-25 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
US10029987B2 (en) | 2009-06-29 | 2018-07-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
US9328077B2 (en) | 2010-12-21 | 2016-05-03 | Agios Pharmaceuticals, Inc | Bicyclic PKM2 activators |
US10087169B2 (en) | 2010-12-21 | 2018-10-02 | Agios Pharmaceuticals, Inc. | Bicyclic PKM2 activators |
US9199968B2 (en) | 2010-12-29 | 2015-12-01 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
US8889667B2 (en) | 2010-12-29 | 2014-11-18 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US10632114B2 (en) | 2011-05-03 | 2020-04-28 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US9980961B2 (en) | 2011-05-03 | 2018-05-29 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US9181231B2 (en) | 2011-05-03 | 2015-11-10 | Agios Pharmaceuticals, Inc | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
US11793806B2 (en) | 2011-05-03 | 2023-10-24 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
US9365545B2 (en) | 2013-03-15 | 2016-06-14 | Agios Pharmaceuticals, Inc | Therapeutic compounds and compositions |
US11234976B2 (en) | 2015-06-11 | 2022-02-01 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
Also Published As
Publication number | Publication date |
---|---|
WO1997015555A2 (de) | 1997-05-01 |
WO1997015555A3 (de) | 1997-07-10 |
ZA969019B (en) | 1997-05-29 |
AU1300997A (en) | 1997-05-15 |
EP0857171A2 (de) | 1998-08-12 |
DE19541146A1 (de) | 1997-04-30 |
JPH11515008A (ja) | 1999-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2235621A1 (en) | Imidazole derivatives and their use as nitrogen monoxide synthase inhibitors | |
RU2280025C9 (ru) | Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами | |
US8492437B2 (en) | 4-substituted phenoxyphenylacetic acid derivatives | |
EP1776347B1 (de) | Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung | |
KR940003494B1 (ko) | 벤젠, 피리딘 및 피리미딘 유도체 | |
US20020006948A1 (en) | 1,2 diarylbenzimdazoles and their pharmaceutical use | |
US20010008898A1 (en) | Ether and amide compounds and preparation of thereof as antidiadetics. | |
CA2482382A1 (en) | Pyrazole compounds as anti-inflammatory and analgesic agents | |
US7345075B2 (en) | 1,2 diarylbenzimidazoles and their pharmaceutical use | |
US4598077A (en) | Amidine derivatives and cardiotonic compositions | |
EP0344577A2 (de) | Buten- oder Propensäure-Derivate | |
KR850000682B1 (ko) | 헤테로사이클릭 화합물의 제조방법 | |
HUT73431A (en) | Process for preparing novel bisoxadiazolidine derivatives and pharmaceutical compositions containing them | |
SK59096A3 (en) | Benzoylguanidine derivative containing fluor, preparation method thereof and pharmaceutical composition containing them | |
KR920006823B1 (ko) | 부텐산 유도체 | |
US4902698A (en) | Benzenesulphonamidopyridyl compounds which are useful as thromboxane A.sub.2 | |
HU196373B (en) | Process for production of of derivatives of heteroaromatic acetilene and medical preparatives containing them | |
AU2004293189A1 (en) | Nitroso derivatives of diphenylamine | |
WO1998000430A1 (de) | Imidazolderivate als stickstoffmonoxid-synthase-inhibitoren | |
HRP20000564A2 (en) | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |